Gender differences in the insulin‐like growth factor axis response to a glucose load
- 6 June 2006
- journal article
- clinical trial
- Published by Wiley in Acta Physiologica
- Vol. 187 (3) , 371-378
- https://doi.org/10.1111/j.1748-1716.2006.01581.x
Abstract
Aims: The insulin‐like growth factors (IGFs) are thought to contribute to glucose homeostasis. The aim of our study was to examine the response of the IGFs and their binding proteins to an intravenous load of glucose in a cohort of young men and women with normal glucose tolerance. Methods: The intravenous glucose tolerance test (IVGTT) was used to quantify insulin sensitivity and insulin secretion in 160 adults aged 20–21 years in Adelaide, Australia. Serum IGF‐I, IGF‐II, IGF‐binding protein (IGFBP)‐1 and IGFBP‐3 were measured during the IVGTT. Results: Women were less insulin sensitive than men with higher fasting insulin (women 55.6 ± 4.4, men 44.1 ± 3.6 pmol L−1, P = 0.001) and first phase insulin secretion (women 3490 ± 286, men 3038 ± 271 pmol L−1 min, P = 0.042). Women showed lower fasting free IGF‐I (women 0.29 ± 0.02, men 0.36 ± 0.02 μg L−1, P = 0.004) but higher IGFBP‐3 (women 46.3 ± 0.53, men 43.3 ± 0.58 mg dL−1, P = 0.001) and higher IGFBP‐1 concentrations (women 37.0 ± 2.9, men 24.8 ± 2.3 μg L−1, P = 0.012). IGFBP‐1 fell by 5 min and remained suppressed. IGFBP‐3 and total IGF‐I fell until 60 min rising again by 2 h. IGF and IGFBP values were all higher in women. IGFBP‐1 showed a negative association with fasting and stimulated insulin concentrations in both genders. First phase insulin secretion however showed positive correlations with IGFBP‐3 (r = 0.321, P = 0.004) and IGF‐I (r = 0.339 P = 0.002) in men but not women. Conclusion: Our data show that IGFBP‐1, IGFBP‐3 and IGF‐I show acute changes following a glucose load and there are marked gender differences in these responses.Keywords
This publication has 38 references indexed in Scilit:
- Gender differences in the relation of insulin‐like growth factor binding protein‐1 to cardiovascular risk factors: a population‐based studyClinical Endocrinology, 2005
- Circulating concentrations of insulin-like growth factor-I and development of glucose intolerance: a prospective observational studyThe Lancet, 2002
- The Effect of Four Weeks of Supraphysiological Growth Hormone Administration on the Insulin-Like Growth Factor Axis in Women and MenJournal of Clinical Endocrinology & Metabolism, 2000
- Free Insulin-Like Growth Factor I (IGF-I) in Healthy Subjects: Relationship with IGF-Binding Proteins and Insulin SensitivityJournal of Clinical Endocrinology & Metabolism, 1997
- Impaired glucose homeostasis in insulin-like growth factor binding protein-1 transgenic mice.Journal of Clinical Investigation, 1996
- Regulation of IGFBP-1 in humansProgress in Growth Factor Research, 1995
- Insulin rapidly decreases insulin-like growth factor-binding protein-1 gene transcription in streptozotocin-diabetic ratsMolecular Endocrinology, 1992
- Effects of insulin-like growth factor-I on glucose tolerance, insulin levels, and insulin secretion.Journal of Clinical Investigation, 1992
- Bone Growth FactorsClinical Orthopaedics and Related Research, 1991
- Abnormal serum growth hormone responses in genetically potential-diabetic male patients with normal oral glucose tolerance: Evidence for an insulin-like action of growth hormone in vivoDiabetologia, 1973